- Home
- GNLX vs CSLMU Comparison
GNLX vs CSLMU Comparison
Compare GNLX & CSLMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- CSLMU
- Stock Information
- Founded
- GNLX 2001
- CSLMU N/A
- Country
- GNLX United States
- CSLMU
- Employees
- GNLX N/A
- CSLMU 3
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- CSLMU
- Sector
- GNLX Health Care
- CSLMU
- Exchange
- GNLX Nasdaq
- CSLMU NYSE
- Market Cap
- GNLX 103.6M
- CSLMU N/A
- IPO Year
- GNLX 2023
- CSLMU N/A
- Fundamental
- Price
- GNLX $2.42
- CSLMU $11.69
- Analyst Decision
- GNLX Strong Buy
- CSLMU
- Analyst Count
- GNLX 4
- CSLMU 0
- Target Price
- GNLX $18.25
- CSLMU N/A
- AVG Volume (30 Days)
- GNLX 116.5K
- CSLMU N/A
- Earning Date
- GNLX 11-14-2024
- CSLMU N/A
- Dividend Yield
- GNLX N/A
- CSLMU N/A
- EPS Growth
- GNLX N/A
- CSLMU N/A
- EPS
- GNLX N/A
- CSLMU N/A
- Revenue
- GNLX $8,000.00
- CSLMU N/A
- Revenue This Year
- GNLX N/A
- CSLMU N/A
- Revenue Next Year
- GNLX N/A
- CSLMU N/A
- P/E Ratio
- GNLX N/A
- CSLMU N/A
- Revenue Growth
- GNLX N/A
- CSLMU N/A
- 52 Week Low
- GNLX $1.60
- CSLMU N/A
- 52 Week High
- GNLX $16.36
- CSLMU N/A
- Technical
- Relative Strength Index (RSI)
- GNLX 48.26
- CSLMU 50.67
- Support Level
- GNLX $2.13
- CSLMU $10.72
- Resistance Level
- GNLX $2.80
- CSLMU $12.99
- Average True Range (ATR)
- GNLX 0.17
- CSLMU 0.00
- MACD
- GNLX 0.00
- CSLMU -0.00
- Stochastic Oscillator
- GNLX 52.24
- CSLMU 0.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About CSLMU CSLM ACQUISITION CORP
CSLM Acquisition Corp, formerly Consilium Acquisition Corp I Ltd is a blank check company.